InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Renschler Markus Md. Director active across 1 company, notably Cyteir Therapeutics, Inc.. Aggregated, 5 filings have been logged. Activity tracked since 21 December 2022. The latest transaction was disclosed on 29 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
RENSCHLER MARKUS MD is linked to Cyteir Therapeutics, Inc., where the listed role is President and CEO. The record shows 5 filings in total, and the sampled recent filings run from 2022-12-23 to 2024-03-05; the modal transaction nature is Option exercise.